Drug X which inhibit the binding of RANKL to its receptor (RANK) in osteoporosis:
Correct Answer: Denosumab
Description: Ans. C. DenosumabOsteoclasts express RANK receptor which on stimulation causes resorption of bone. Denosumab is monoclonal antibody which inhibit the binding of ligand to the receptor and thus play a role in osteoporosis.
Category:
Pharmacology
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now